bioAffinity Technologies Presents CyPath® Technology at International Lung Cancer Conference
April 12, 2016 09:00 ET
|
bioAffinity Technologies, Inc.
SAN ANTONIO, April 12, 2016 (GLOBE NEWSWIRE) -- bioAffinity Technologies, a privately held cancer diagnostics company, will present its proprietary technology for the detection of early-stage lung...